Starving pancreatic cancer cells: Scientists identify potential pancreatic cancer target

Researchers have found that a protein called SLC6A14 is overexpressed by several fold in pancreatic tumors taken from patients and in cancerous pancreatic cells lines compared with normal pancreatic tissue or normal pancreatic cells. SLC6A14 transports amino acids into cells to help with cellular metabolism.

A blocker of SLC6A14, called α-methyltryptophan, induced amino acid starvation in cells and reduced the growth and proliferation of these cells, both in laboratory dishes and in mice.

"Finally, a novel strategy to treat pancreatic cancer: starve it to death!" said Dr. Yangzom Bhutia, senior author of the British Journal of Pharmacology study. "Pancreatic cancer recruits the transporter SLC6A14 to satisfy its increasing demands for amino acids; our studies show that if we block this transporter with a drug, we can effectively starve this cancer to death."November is Pancreatic Cancer Awareness Month, and World Pancreatic Cancer Day is November 17th.

Explore further

Detecting an early biomarker for pancreatic cancer in blood

More information: V Coothankandaswamy et al, Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer, British Journal of Pharmacology (2016). DOI: 10.1111/bph.13616
Journal information: British Journal of Pharmacology

Provided by Wiley
Citation: Starving pancreatic cancer cells: Scientists identify potential pancreatic cancer target (2016, October 17) retrieved 21 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more